Improving executive functioning in teens with epilepsy through a web-based intervention

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a web-based intervention called Epilepsy Journey, designed to enhance executive functioning in adolescents with epilepsy. Participants aged 13-17 will be randomly assigned to one of four groups: receiving both web-based modules and telehealth sessions, web-based modules only, telehealth sessions only, or standard treatment. The study will assess which components of the intervention are most effective in improving executive functioning and quality of life. The trial addresses a significant gap in interventions for this vulnerable population, as deficits in executive functioning are prevalent among youth with epilepsy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age between 13-17 years at the time of enrollment
2. Child lives at home with primary caregiver and is enrolled in school (excluding summer breaks).
3. Confirmed diagnosis of epilepsy with seizures that are categorized as either generalized or focal in onset. Epilepsy is defined as: 1) At least two unprovoked seizures occurring more than 24-hours apart; or 2) One unprovoked seizure and a probability of further seizures similar to the general recurrence risk after two unprovoked seizures.
4. Primary language of English
5. Screening Inclusion: On the parent-reported Behavior Rating Inventory of Executive Function-2nd edition (BRIEF-2), have executive functioning deficits defined as at least 2 subclinical (60\<T\<65) or one clinical BRIEF-2 subscale T scores (T≥65).
6. Parent/legal guardian(s) willing to sign an IRB approved informed consent
7. Participant willing to sign an Institutional Review Board approved assent

Exclusion Criteria:

1. Parent or clinician-reported history in the adolescent of:

   1. developmental delay (e.g., autism spectrum disorder, pervasive development disorder, history of services for developmental delay or intellectual impairment in the past 5 years, known IQ\<70)
   2. severe mental illness (e.g., schizophrenia, bipolar disorder, eating disorder within the past 12 months, depression with active suicidal ideation or suicidal ideation/intent in the past 3 months)
   3. prior (3-months) or current history of trauma and/or stressor-related disorders (e.g. PTSD)
   4. recent or current significant medical disease (i.e., cardiovascular, hepatic, renal, gynecologic, musculoskeletal, metabolic or endocrine)
   5. brain injury or brain tumor; and/or
   6. epilepsy surgery
   7. any other medical and/or psychological condition that takes treatment precedence over the study intervention
2. Clinician-reported diagnosis in the adolescent of

   1. epilepsy whose seizures are categorized only as either unknown onset or unclassified onset (defined as insufficient information to determine onset)
   2. epilepsy currently being treated at the time of enrollment by 3 or more antiseizure medications (ASMs) (excluding rescue medication use)
   3. epilepsy with a history of failure to achieve seizure freedom despite adequate use of 4 different anti-seizure medications
   4. a confirmed or suspected epileptic encephalopathy (e.g., electrical status epilepticus in sleep, Landau Kleffner syndrome, West syndrome)
   5. a confirmed or suspected progressive and degenerative disorder (e.g., mitochondrial disorders, metabolic disorders, autoimmune disorders)
   6. one or more episodes of status epilepticus within the 24 weeks prior to enrollment; and/or
   7. treatable causes of seizures, for example identified etiologies including metabolic, neoplastic, or active infectious origin.
   8. non-epileptic event/seizures
3. Adolescents currently on the ketogenic diet
4. Participation in a trial of an investigational drug or device within 30 days prior to screening

Where it's running

• Childrens Hospital of Orange County
  Orange, California, United States Recruiting
• Cincinnati Children's Hospital Medical Center
  Cincinnati, Ohio, United States Recruiting
• Medical University of South Carolina
  Charleston, South Carolina, United States Recruiting

Study contacts

• Principal investigator: Avani Modi, Ph.D. — Children's Hospital Medical Center, Cincinnati
• Study coordinator: Avani C Modi, Ph.D.
• Email: avani.modi@cchmc.org
• Phone: 513-636-4864

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sleep and Music for Kids with Epilepsy

  This trial tests if a music-based program can improve sleep and health for children with epilepsy and their parents.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07696442

• Personalized E-Fit program to help executive skills in kids with complex congenital heart disease

  A tailored digital training program called E-Fit tests whether targeted brain-training, online coaching, and hands-on games can improve everyday executive skills in 9- to 13-year-olds who have complex congenital heart disease.

  Recruiting University Children's Hospital, Zurich · Zurich, Canton of Zurich · NCT07692958

• Intensive neurofeedback for children with ADHD: personalized vs. standard theta-beta training

  This study tests two neurofeedback approaches in children with ADHD to see if a personalized, iAPF-based theta-beta training works better than a standard theta-beta training.

  Recruiting at 2 sites Bielefeld University · Bielefeld and 1 other locations · NCT07595783

• Methylphenidate for attention and executive problems in children with sickle cell disease

  This study will test whether once-daily extended-release methylphenidate for 4 weeks helps attention and thinking skills in children 8–17 with sickle cell disease while monitoring side effects and adherence.

  Recruiting Phase 1 St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07226219

• Transcranial direct current stimulation plus ABA to boost language and executive skills in children with autism.

  This project will test whether adding low-level electrical brain stimulation (tDCS) to applied behavior analysis helps children ages 5–12 with autism learn language and executive function skills better.

  Recruiting New York State Institute for Basic Research · Staten Island, New York · NCT07092280

• Registry and natural history of epilepsy-dyskinesia syndromes

  This registry will collect health data and biological samples from people of all ages who have a genetic diagnosis of epilepsy-dyskinesia syndromes to see how their genes relate to their movement and seizure symptoms over time.

  Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT06967727

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.